Mapk1 in its phosphorylated form accumulates in dying neurons in Alzheimer's disease [28] which indicates a risk for toxicity with prolonged PCP treatment. This evidence concerns the gene MAPK1 and early-onset autosomal dominant Alzheimer disease.